463 related articles for article (PubMed ID: 8844631)
1. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Saure A; Planellas J; Poulsen HK; Jaszczak P
Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
[TBL] [Abstract][Full Text] [Related]
3. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
Lübbert H; Nauert C
Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
[TBL] [Abstract][Full Text] [Related]
5. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
Reginster JY; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet AN; Franchimont P
Calcif Tissue Int; 1993 Jul; 53(1):13-6. PubMed ID: 8394191
[TBL] [Abstract][Full Text] [Related]
6. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Sendağ F; Terek MC; Karadadaş N; Bilgin O
J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
[TBL] [Abstract][Full Text] [Related]
10. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
12. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo.
Murkes D; Lalitkumar PG; Leifland K; Lundström E; Söderqvist G
Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():12-5. PubMed ID: 22834417
[TBL] [Abstract][Full Text] [Related]
14. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.
Greendale GA; Reboussin BA; Hogan P; Barnabei VM; Shumaker S; Johnson S; Barrett-Connor E
Obstet Gynecol; 1998 Dec; 92(6):982-8. PubMed ID: 9840563
[TBL] [Abstract][Full Text] [Related]
15. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
[TBL] [Abstract][Full Text] [Related]
16. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
[TBL] [Abstract][Full Text] [Related]
17. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
[TBL] [Abstract][Full Text] [Related]
18. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
[TBL] [Abstract][Full Text] [Related]
19. Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.
Koh KK; Ahn JY; Jin DK; Yoon BK; Kim HS; Kim DS; Shin MS; Son JW; Choi IS; Shin EK
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1459-64. PubMed ID: 12231566
[TBL] [Abstract][Full Text] [Related]
20. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]